Angizaar 25mg 10 Tablets

Babies: Not applicable. Lactating mother: Angizaar tablet is safe to use during breastfeeding. Human studies have shown that this drug may not pass into breast milk and does harm the baby. Pregnancy: Angizaar tablet is not safe to use during pregnancy because this drug may cause harmful effects on the developing baby.
Consult your doctor. Alcohol: It is not safe to drink alcohol while taking this medication. Driving: It is not known clearly whether it is safe to use while driving.
Do not drive if any symptoms affect your ability to drive. Kidney: Angizaar tablet is safe to use in patients with kidney disease. Consult your doctor.
Dose adjustment is not required. Monitor blood pressure regularly. Liver: Angizaar tablets should be used with caution in patients with liver disease.
Consult your doctor. You should not prescribe this medication to patients with severe liver disease..

Dizziness Decreased blood pressure Hypoglycemia Increased potassium level in blood Increased blood urea.

It works by blocking the action of a hormone called angiotensin 2 and relaxes blood vessels. Hence, it allows the blood to flow smoothly and reduces blood pressure.
.

If you miss a dose, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• It can be taken with or without food, but take at a fixed time • This medication may cause dizziness, so get up slowly from sitting or lying position • Your doctor may advise specific tests to be monitored regularly like urea, creatinine, and potassium levels in your blood • Consult your doctor before taking anti-inflammatory medicines like ibuprofen while taking this medication • Inform your doctor if you are pregnant or breastfeeding • Medication must not be stopped unless told by your doctor.

Contraindicated: • Angizaar + Aliskiren: Concurrent use may result in an increased risk of hyperkalemia, renal impairment, and hypotension Major: • Angizaar + Benazepril: Concurrent use may result in an increased risk of adverse events (hypotension, syncope, hyperkalemia, changes in renal function, and acute renal failure) • Angizaar + Captopril: Concurrent use may result in an increased risk of adverse events (hypotension, syncope, hyperkalemia, changes in renal function, and acute renal failure) • Angizaar + Clarithromycin: Concurrent use may result in increased exposure to clarithromycin and risk of toxicity • Angizaar + Enalapril: Concurrent use may result in an increased risk of adverse events (hypotension, syncope, hyperkalemia, changes in renal function, and acute renal failure) • Angizaar + Potassium phosphate: Concurrent use may result in an increased risk of severe and potentially fatal hyperkalemia • Angizaar + Trimethoprim: Concurrent use may result in an increased risk of hyperkalemia • Angizaar + Amiloride: Concurrent use may result in an increased risk of hyperkalemia.